By

Gisela Pairo
Courtney is a Trial Manager in the Stress, Psychiatry and Immunology (SPI) Lab at the IOPPN, Kings College London. What drew you to psychiatric research? I grew up in a time where the importance of mental health was on the raise. Besides, I had a genuine desire to help people. And what better way to...
Read More
The context of emergency generated by COVID-19 has not held back EU-PEARL’s Consortium in advancing towards the new paradigm of clinical trials. In fact, this pandemic has highlighted the need to develop a novel framework in the field of clinical research that can facilitate a more agile response to global health challenges. This was the focus of the keynote...
Read More
The Innovative Medicines Initiative (IMI), funder of EU-PEARL, recently highlighted in a news feature the contribution the project is making to shape a novel framework to conduct platform trials. As way of example, the article focused on WHO Solidarity clinical trial -which is testing multiple COVID-19 treatments- to explain what an adaptive trial is and...
Read More
This past November marked the first 12 months of EU-PEARL. A fruitful time in which the project Consortium has largely focused on laying the foundations to start developing the innovative IRP framework. Once in place, this new paradigm which deepens into the adaptive platform trials approach, will bring more efficacy and speed to the drug...
Read More
Driven by its mission to bring patient centricity to the core of the project’s activities, this year, EU-PEARL inaugurated a Patient Advisory Group (PAG) and an Expert Advisory Group (EAG). The PAG, which held its kick-off meeting on 16 September, is composed of representatives from the four project disease areas (NASH, Major Depressive Disorder, Neurofibromatosis, Tuberculosis), and other diseases areas.  ...
Read More
With the aim to bring science and researchers closer to the general public and stimulate interest in research careers – particularly among young people, the European Researchers’ Night will take place next November 27th in a virtual format. Lada Murcia, Biomedical Scientist at Vall d’Hebron Research Institute and project manager at EU-PEARL will deliver and...
Read More
The Methods in Oncology scientific working group of the American Statistical Association (ASA)  in collaboration with the  FDA Oncology Center of Excellence (OCE) will hold a forum on “Type I error Considerations in Master Protocols with Common Control in Oncology Clinical Trials” next October, 8th. Martin Posch, professor of Medical Statistics at the Medical University...
Read More
DIA’s Master Protocol Workshop will take place next October 8th and 9th online. The two-day event will focus on design, planning, implementation, and evolving operational best practices through the lens of Master Protocol trial stakeholders. Cecile Spiertz, Senior Director of External Innovation Clinical Trial Platform at Janssen and Benjamin Hofner, Head of Section Biostatistics at...
Read More
Statisticians in the Pharmaceutical Industry (PSI) will hold a webinar on Master protocols – theory, application and regulatory considerations next September 23rd. The event is addressed to experts on master protocols from the pharmaceutical industry, academia, and regulatory agencies. Martin Posch, professor of Medical Statistics at the Medical University of Vienna, head of the Center...
Read More
Creating a collaborative environment integrated by a diversity of stakeholders is vital to move forward on the innovative paradigm of Integrated Research Platforms (IRPs). Next October, experts from health authorities, ethic committees, patient organizations, health technology assessments, industry/pharmaceutical companies and academic investigators/hospital networks involved in drug development are called to attend EU-PEARL’s first Stakeholder Workshop...
Read More
1 4 5 6 7 8

Sign up to stay informed


    We will process your data to deliver our quarterly updates to your inbox. You can view our Privacy Policy here or contact us at info@eu-pearl.eu